risperidone has been researched along with Foot Diseases in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Foot Diseases: Anatomical and functional disorders affecting the foot.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yaluğ, I | 1 |
Ozten, E | 1 |
Evren Tufan, A | 1 |
Alemdar, M | 1 |
Cerit, C | 1 |
1 other study available for risperidone and Foot Diseases
Article | Year |
---|---|
Bilateral pedal edema associated with olanzapine use in manic episode of bipolar disorder: report of two cases.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Edema; Electrolytes; Female; Foot Di | 2007 |